⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3837768 | 0.67 | — | — | |
| SCHEMBL13993232 | 0.67 | — | — | |
| Hydroxyl Radical SCHEMBL10318496 | 0.65 | — | — | |
| SCHEMBL11320048 | 0.59 | — | — | |
| SCHEMBL96148 | 0.56 | — | — | |
| SCHEMBL3157149 | 0.54 | — | — | |
| SCHEMBL125283 | 0.54 | — | — | |
| SCHEMBL28675893 | 0.54 | — | — | |
| Methane SCHEMBL23217135 | 0.53 | — | — | |
| SCHEMBL8232641 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115246921-A | Blocked polyisocyanate composition, hydrophilic polyisocyanate composition, resin film, and laminate | 旭化成株式会社 | 2022-10-28 | — | — | CN | disclosed |
| CN-112300365-B | Blocked polyisocyanate composition, hydrophilic polyisocyanate composition, resin film, and laminate | 旭化成株式会社 | 2022-08-12 | — | — | CN | disclosed |
| CN-112300365-A | Blocked polyisocyanate composition, hydrophilic polyisocyanate composition, resin film, and laminate | 旭化成株式会社 | 2021-02-02 | — | — | CN | disclosed |
| EP-2875001-B1 | NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS | SUNSHINE LAKE PHARMA CO LTD (CN) | 2019-01-09 | — | — | EP | disclosed |
| US-9434695-B2 | Nitrogenous heterocyclic derivatives and their application in drugs | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2016-09-06 | — | — | US | disclosed |
| EP-2875001-A1 | NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS | Sunshine Lake Pharma Co., Ltd. (CN) | 2015-05-27 | — | — | EP | disclosed |
| US-20150087639-A1 | Nitrogenous Heterocyclic Derivatives And Their Application In Drugs | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2015-03-26 | — | — | US | disclosed |
| WO-2014012360-A1 | NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-01-23 | — | — | WO | disclosed |
| WO-2013175281-A1 | USE OF SUBSTITUTED 2-PHENYL-3H-QUINAZOLIN-4-ONES AND ANALOGS FOR INHIBITING BROMODOMAIN AND EXTRA TERMINAL DOMAIN (BET) PROTEINS | RVX THERAPEUTICS INC. (CA) | 2013-11-28 | — | — | WO | disclosed |